StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Jaffray Downgrades Gilead Sciences (GILD) to Neutral
October 26, 2018 4:41 AM
Piper Jaffray analyst Tyler Van Buren downgraded Gilead Sciences (NASDAQ: GILD) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Downgrades
Hot Downgrades
Next Articles
Gilead Sciences (GILD) Reports 96-Wk Data from Phase 3 Study of Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for HIV-1 Treatment in Adults New to HIV Therapy
October 30, 2018 7:17 AM
Gilead Sciences (GILD) PT Lowered to $87 at RBC Capital
October 26, 2018 7:24 AM